Murepavadin

DRUG2 trials

Sponsors

Polyphor Ltd.

Conditions

Pneumonia

Phase 3

Pivotal Study in VAP Suspected or Confirmed to be Due to Pseudomonas Aeruginosa

TerminatedNCT03409679

Polyphor Ltd.Pneumonia

Start: 2018-03-23End: 2019-07-17Updated: 2019-08-28

Pivotal Study in Nosocomial Pneumonia Suspected or Confirmed to be Due to Pseudomonas

TerminatedNCT03582007

Polyphor Ltd.Pneumonia

Start: 2018-10-22End: 2019-07-17Updated: 2019-08-28